Clinical Trial: Efficacy of Parecoxib on Patients With CRPS

Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access

Official Title: Efficiacy of the Selctive COX-2-inhibitor Parecoxibe on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS)

Brief Summary: The complex regional pain syndrom is a weighty disease that often results in a lifelong disability. Mostly this disease appears unilateral after comparatively mundane fractures or operations. In early stages CRPS shows inflammatory processes. These inflammatory components can be seen as edema and vasodilatation. These inflammatory processes lead us to the hypothesis that selective COX-2-inhibitors might help patients with CRPS.

Detailed Summary:
Sponsor: Ruhr University of Bochum

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Ruhr University of Bochum

Dates:
Date Received: January 31, 2012
Date Started:
Date Completion:
Last Updated: April 24, 2012
Last Verified: April 2012